首頁 > 市場調查報告書 > 醫療設備

體外診斷

移植診斷市場規模、佔有率和成長分析（按技術、產品和服務、應用、移植類型、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897673

移植診斷市場規模、佔有率和成長分析（按技術、產品和服務、應用、移植類型、最終用戶和地區分類）－2026-2033年產業預測

Transplant Diagnostics Market Size, Share, and Growth Analysis, By Technology (Molecular Assay Technologies, Pcr-Based Molecular Assays), By Product & Services, By Application, By Transplant Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，移植診斷市場規模將達到 48.7 億美元，到 2025 年將達到 52.5 億美元，到 2033 年將達到 95.8 億美元，預測期（2026-2033 年）的複合年成長率為 7.8%。

移植診斷市場正經歷強勁成長，這主要得益於器官移植需求的不斷成長和診斷技術的持續進步。慢性疾病的普遍流行也推動了這一成長，而這些疾病往往會導致器官衰竭。隨著對準確且高效的移植相容性檢測需求的增加，預計該市場將進一步擴張，從而改善患者預後並提高移植成功率。一個值得關注的趨勢是人工智慧 (AI) 和機器學習 (ML) 的融合。這些技術能夠簡化對包括基因組和臨床資訊在內的海量資料集的分析，實現模式識別和相容性預測，從而最佳化器官分配。這些技術的應用有望顯著提高移植診斷的準確性和效率，最大限度地利用資源並改善患者照護。

移植診斷市場促進因素

末期腎功能衰竭、心臟衰竭和肝硬化等慢性疾病發生率的不斷上升是推動器官移植需求的關鍵因素。這些嚴重的疾病往往需要透過器官移植來改善患者的生活品質和健康狀況。此外，患者和醫療保健提供者對器官移植益處的認知不斷提高，進一步加劇了對移植診斷的需求。對捐贈者相容性檢測的日益重視，為該領域的進步創造了機遇，最終推動了移植診斷市場的擴張，因為相關人員在尋求準確且高效的解決方案。

移植診斷市場限制因素

由於器官移植需求旺盛而合適器官供應有限，移植診斷市場面臨巨大的限制。器官短缺導致患者等待移植的時間過長，增加了患者在等待期間的死亡風險和病情惡化。器官短缺不僅限制了移植手術的數量，也限制了相關診斷產品和服務的市場潛力。此外，不同地區關於器官捐贈的倫理問題、法律限制和文化態度進一步加劇了器官短缺，阻礙了移植診斷領域的發展。

移植診斷市場趨勢

移植診斷產業的關鍵市場趨勢是擴大整合先進技術，例如次世代定序（NGS），這正在改變供體和受體的配型方式。這種創新方法能夠實現高通量基因分析，從而對人類白血球抗原（HLA）系統和其他重要的遺傳標記進行全面分析。 NGS可以識別更廣泛的HLA等位基因並發現罕見突變，從而提高配對準確性，並有助於做出更準確、更明智的移植決策。這項技術進步不僅簡化了診斷流程，而且有望改善移植結果，最終降低移植物排斥的發生率，並最大限度地提高移植物長期存活率。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Bio-Rad Laboratories, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
Omixon Ltd.（Estonia）
Hologic, Inc.（USA）
Immucor, Inc.（USA）
CareDx, Inc.（USA）
Qiagen NV（Netherlands）
BioGenuix, Inc.（USA）
F. Hoffmann-La Roche AG（Switzerland）
Fujifilm Holdings Corporation（Japan）
Eurofins Scientific SE（Luxembourg）
Genomatica, Inc.（USA）
Illumina, Inc.（USA）
Oxford Nanopore Technologies plc（UK）
Pacific Biosciences of California, Inc.（USA）
NanoString Technologies, Inc.（USA）
Fluidigm Corporation（USA）
Agilent Technologies, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2553

Transplant Diagnostics Market size was valued at USD 4.87 Billion in 2024 and is poised to grow from USD 5.25 Billion in 2025 to USD 9.58 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The Transplant Diagnostics market is experiencing robust growth, driven by heightened demand for organ transplantation and continuous advancements in diagnostic technologies. The prevalence of chronic diseases contributing to organ failures further fuels this growth. As the necessity for precise and efficient transplant compatibility testing escalates, the market is poised for further expansion, enhancing patient outcomes and transplant success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML), which streamline the analysis of extensive data sets, encompassing genomic and clinical information. These technologies enable the identification of patterns and prediction of compatibility, ultimately optimizing organ allocation. Their implementation promises to significantly improve the accuracy and efficiency of transplant diagnostics, thus maximizing resource utilization and patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transplant Diagnostics Market Segments Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transplant Diagnostics Market

The increasing incidence of chronic illnesses, including end-stage renal disease, heart failure, and liver cirrhosis, is a significant factor contributing to the demand for organ transplants. These serious medical conditions frequently necessitate transplantation to enhance patients' quality of life and health outcomes. Additionally, rising awareness among patients and healthcare providers regarding the advantages of organ transplantation has further amplified the need for transplant diagnostics. This heightened focus on compatibility testing between donors and recipients has created opportunities for advancements in this field, ultimately driving the expansion of the transplant diagnostics market as stakeholders seek accurate and efficient solutions.

Restraints in the Transplant Diagnostics Market

The Transplant Diagnostics market faces significant restraints due to the imbalance between the high demand for organ transplants and the limited availability of suitable organs. This scarcity results in extended waiting lists for patients, heightening the risk of mortality or disease progression during the wait. The shortage of organs not only limits the number of transplant procedures but also constrains the market potential for related diagnostic products and services. Furthermore, ethical issues, legal regulations, and cultural attitudes towards organ donation in various regions further exacerbate the organ shortage, thereby hindering the growth and advancement of the transplant diagnostics sector.

Market Trends of the Transplant Diagnostics Market

A significant market trend in the transplant diagnostics industry is the growing integration of advanced technologies such as next-generation sequencing (NGS), which is transforming the landscape of donor-recipient matching. This innovative approach facilitates high-throughput genetic profiling, allowing for comprehensive analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. NGS enhances precision in matching by identifying a broader spectrum of HLA alleles and unveiling rare variants, thus driving more accurate and informed transplant decisions. This technological advancement not only streamlines the diagnostic process but also holds the promise of improved transplant outcomes, ultimately reducing the incidence of graft rejection and maximizing long-term graft survival rates.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Molecular Assay Technologies
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sequence-Specific Primer-Pcr
- Sequence-Specific Oligonucleotide-Pcr
- Other Pcr-Based Molecular Assays
Sequencing Based Molecular Assays
- Sanger Sequencing
- Next Generation Sequencing
- Other Sequencing Based Molecular Assays
Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Reagents & Consumables
Instruments
Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostic Application
- Pre-Transplantation Diagnostics
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
- Post -Transplantation Diagnostics
Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2026-2033)

Market Overview
Solid Organ Transplantation
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Pancreas Transplantation
- Other Organs Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals And Transplant Centers
Research & Academic Institutes
Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2026-2033)

North America (Technology, Product & Service, Application, Transplant Type, End User)
- USA
- Canada
Europe (Technology, Product & Service, Application, Transplant Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product & Service, Application, Transplant Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omixon Ltd. (Estonia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenuix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomatica, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments